Eli Lilly/Boehringer Ingelheim published a study claiming that duloxetine (Cymbalta) was an effective treatment for pain in depressed patients.Nothin...
I don't have time to write much on the topic, suffice to say that John Russell of the Indianapolis Star raises some good questions about Cymbalta, Eli...
The anti-depressant Cymbalta (duloxetine), marketed by Lilly, has received FDA approval for the treatment of fibromyalgia. While certain anti-depressa...
Philip Dawdy at Furious Seasons has noted that Eli Lilly released a short report in which they describe the funding they provided to a variety of orga...
I'm late to the game on this post, and this material has been covered well on other sites. In case you've missed it, a recent meta-analysis indicated...
In the past ten days, a few different blog entries have been written calling our attention to a meta-analysis that suggests perhaps Cymbalta (duloxot...
Following last week's chart displaying the quantitative overview of FDA's DDMAC issuance of Warning Letters and Untitled Letters, I wanted to begin th...
I've been debating all week whether I'm down or if my clinical depression is creeping back. Arriving a day late for the psychiatry appointment I sched...
Subscribe
.gif)
achoo! The Blog
Dr. Weil's Healthy Living
World of Psychology